AMSTERDAM, November 14, 2017 /PRNewswire/ --
- Two year study* found that
clinicians' use of Azurion enabled
significant reductions in procedure
time, in-lab patient preparation time, post-procedure lab
time and enhanced staff experience
- Improvements correspond to the ability to
treat one additional patient per interventional lab
per day, or several hundred patients per lab per
year
- Launched in February 2017,
Azurion was developed in collaboration with leading
hospitals worldwide, and allows clinicians to easily and
confidently perform a wide range of routine and complex procedures,
helping them to optimize interventional lab performance and provide
superior care
Royal Philips (NYSE: PHG)( AEX: PHIA), a global leader in health
technology, today announced the results of a comprehensive,
independent, two-year study demonstrating the clinical workflow
benefits of its next generation image-guided therapy platform,
Azurion. The study investigated nearly 800 patient procedures to
evaluate the impact of Azurion at St. Antonius Hospital in
Nieuwegein, the Netherlands. The
data demonstrated clinicians' use of Azurion resulted in
significant time savings for the hospital, including a 17 percent
reduction of the average interventional procedure time, a 12
percent reduction of in-lab patient preparation time, and a 28
percent reduction of post-procedure lab time.
(Photo:
http://mma.prnewswire.com/media/602887/Philips_Azurion_Hospitals.jpg
)
(Photo:
http://mma.prnewswire.com/media/602889/Philips_Azurion_Infographic.jpg
)
(Photo:
http://mma.prnewswire.com/media/602888/Philips_Azurion_Improvements.jpg
)
"As the use of image-guided therapies continue to rise, new
systems need to be easy and intuitive to use so clinicians can
quickly and efficiently move through procedures," said Marco van
Strijen, MD, Interventional Radiologist, St. Antonius Hospital.
"With the Azurion system, we were able to change our workflow in
such a way that we now can do more patients in a single day,
resulting in more patients a week, resulting in more patients per
year, with no compromise to patient safety or quality of care."
Overall, the improvements achieved with Azurion will give St.
Antonius Hospital the ability to treat one more patient per day -
on an average of 6 to 8 patients per day, to help hundreds more
patients each year. The reduced preparation, procedure and lab time
resulted in fewer planned cases finishing after normal working
hours and higher employee satisfaction. St. Antonius Hospital,
treating more than 93,000 patients annually, was among the first
hospitals to install Azurion and participated in this comprehensive
study to evaluate the impact of the new platform and its clinical
workflow on their department.
"Hospitals are facing a hard to predict and growing patient
demand and needed a solution that provides impactful clinical and
operational improvements," said Ronald Tabaksblat, Business Leader
Image Guided Therapy Systems. "Less than a year after Azurion's
official launch, we're delighted with these impressive results that
clearly demonstrate how Azurion's state-of-the-art technology and
flexible workflows are helping hospitals increase efficiency and
optimize patient care."
Future of image-guided therapy
Azurion is Philips' next generation image-guided therapy platform
and the new core of its integrated image-guided therapy solutions
portfolio. Azurion supports a full range of configurations across a
broad spectrum of image-guided therapy procedures. It helps
physicians perform interventional procedures through an intuitive
interface and easy-to-use controls for clinical image capture,
decreasing procedure times and allowing for more accurate
scheduling of patients. Additionally, Azurion makes it easier for
staff to anticipate and see the information they need, when they
need it, helping procedures flow more efficiently and easily.
Since its global introduction in February
2017, over 20,000 patients have been treated in 24 countries
across the world. St. Antonius Hospital is the first of a series of
hospital studies. In 2018 more hospitals worldwide will share
results demonstrating Azurion's impact and benefits in improving
clinical workflow and ultimately optimizing patient care.
"The success achieved was possible due to the deep and trusted
partnership we have with Philips." said Wout Adema, member of the Santeon Procurement
Board and Chief Financial Officer, St. Antonius Hospital. "The
Azurion installation provided our interventional team the
opportunity to evaluate our existing processes and standardize
workflows. This helped us make tangible and significant operational
improvements in the short-term, and fostered a continuous
improvement culture amongst the team. The positive impact on
patient and staff satisfaction further contributes to our
reputation as a leading vascular institute".
Visit Philips at the RSNA 2017 Annual meeting
During the Radiological Society of North
America's (RSNA) 2017 Annual Meeting, November 26 to December 2, 2017 in Chicago, attendees will have the opportunity
to experience Azurion first-hand at the Philips booth #6735. Find
out more online here or visit http://www.philips.com/labperformance
to learn more about the study.
*Results verified by NAMSA, independent third-party expert on
study design and analytics
About Royal
Philips
Royal Philips (NYSE: PHG) (AEX:
PHIA) is a leading health technology company focused on improving
people's health and enabling better outcomes across the health
continuum from healthy living and prevention, to diagnosis,
treatment and home care. Philips leverages advanced technology and
deep clinical and consumer insights to deliver integrated
solutions. Headquartered in the
Netherlands, the company is a leader in diagnostic imaging,
image-guided therapy, patient monitoring and health informatics, as
well as in consumer health and home care. Philips' health
technology portfolio generated 2016 sales of EUR 17.4 billion and employs approximately 73,000
employees with sales and services in more than 100 countries. News
about Philips can be found at
http://www.philips.com/newscenter.
For further information, please contact:
Steve Klink
Philips Group Press Office
Tel: +31-6-108-888-24
Email: steve.klink@philips.com
Fabienne van der Feer
Philips Image Guided Therapy
Tel: +31-6-226-98-001
E-mail: fabienne.van.der.feer@philips.com